Letter to the Editor January 1, 2004

Valproate for Hostility in Schizophrenia Patients

Kimberly H. Littrell; Richard G. Petty; Nicole M. Hilligoss; Carol D. Kirshner; Craig G. Johnson

J Clin Psychiatry 2004;65(1):134-134

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Agitation, aggression, and hostility are frequent manifestations of psychiatric illnesses, with symptoms ranging from mild irritability to marked physical violence. "The Expert Consensus Guidelines: Treatment of Schizophrenia"1 recommends valproate as a first-line adjunctive therapy for hostility/aggression, indicating that there is a subgroup of schizophrenia patients whose hostility and aggression persist despite adequate antipsychotic therapy. Research suggests that valproate demonstrates efficacy in the treatment of agitation and impulsive aggression in psychiatric patients.2,3 The current study was designedto evaluate the efficacy of adjunctive valproate in schizophrenia outpatients who exhibit persistent hostility despite prolonged olanzapine therapy